Provectus Biopharmaceuticals Inc (PVCT)
0.1949
0.00 (0.00%)
USD |
OTCM |
May 01, 15:55
Provectus Biopharmaceuticals Max Drawdown (5Y): 96.24% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 96.24% |
| March 31, 2024 | 96.24% |
| February 29, 2024 | 96.24% |
| January 31, 2024 | 96.24% |
| December 31, 2023 | 98.32% |
| November 30, 2023 | 98.32% |
| October 31, 2023 | 98.37% |
| September 30, 2023 | 98.39% |
| August 31, 2023 | 98.39% |
| July 31, 2023 | 98.39% |
| June 30, 2023 | 98.39% |
| May 31, 2023 | 98.39% |
| April 30, 2023 | 98.39% |
| March 31, 2023 | 98.39% |
| February 28, 2023 | 98.39% |
| January 31, 2023 | 98.39% |
| December 31, 2022 | 98.39% |
| November 30, 2022 | 98.39% |
| October 31, 2022 | 98.39% |
| September 30, 2022 | 98.75% |
| August 31, 2022 | 98.87% |
| July 31, 2022 | 99.17% |
| June 30, 2022 | 99.23% |
| May 31, 2022 | 99.35% |
| April 30, 2022 | 99.35% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.35% |
| February 28, 2022 | 99.35% |
| January 31, 2022 | 99.35% |
| December 31, 2021 | 99.35% |
| November 30, 2021 | 99.45% |
| October 31, 2021 | 99.47% |
| September 30, 2021 | 99.63% |
| August 31, 2021 | 99.63% |
| July 31, 2021 | 99.63% |
| June 30, 2021 | 99.63% |
| May 31, 2021 | 99.63% |
| April 30, 2021 | 99.63% |
| March 31, 2021 | 99.63% |
| February 28, 2021 | 99.63% |
| January 31, 2021 | 99.63% |
| December 31, 2020 | 99.63% |
| November 30, 2020 | 99.63% |
| October 31, 2020 | 99.63% |
| September 30, 2020 | 99.63% |
| August 31, 2020 | 99.63% |
| July 31, 2020 | 99.63% |
| June 30, 2020 | 99.63% |
| May 31, 2020 | 99.63% |
| April 30, 2020 | 99.63% |
| March 31, 2020 | 99.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.24%
Minimum
Jan 2024
99.63%
Maximum
May 2019
99.02%
Average
99.46%
Median
Max Drawdown (5Y) Benchmarks
| Insmed Inc | 63.30% |
| NeuroMetrix Inc | 99.78% |
| Intra-Cellular Therapies Inc | 87.64% |
| Rhythm Pharmaceuticals Inc | 92.10% |
| Amylyx Pharmaceuticals Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 25.38 |
| Beta (5Y) | 0.6864 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.52% |
| Historical Sharpe Ratio (5Y) | 0.3532 |
| Historical Sortino (5Y) | 1.148 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.22% |